IMPETO MEDICAL at DDG, Leipzig (Germany)
We will exhibit EZSCAN and SUDOSCAN+ from 1-4th June 2011.
IMPETO MEDICAL at ADA (American Diabetes Association) congress, San Diego, California (USA)
We will exhibit SUDOSCAN at the 71st Scientific Sessions of the ADA (American Diabetes Association) from 24-28th June 2011.
IMPETO MEDICAL at EASD (European Association for the Study of Diabetes) congress, Lisbon (Portugal)
We will exhibit EZSCAN and SUDOSCAN+ from 12 to 16 September 2011.
IMPETO MEDICAL à SFD 2011 (Société Francophone du diabète), Genève (Suisse)
Nous avons présenté SUDOSCAN+ au congrès de la SFD (Société Francophone du Diabète) du 22 au 25 mars 2011.
IMPETO MEDICAL at Prediabetes 2011, Madrid (Spain)
We exhibited EZSCAN at Prediabetes 2011 from 6-9th April 2011. Stand n°11.
Ali Bin ALi at the AACE-Gulf Conference On Diabetes, Obesity And Other Endocrine Diseases (Qatar)
Our distributor in Qatar has presented EZSCAN from 14-16th January 2011.
GulfMed at Arab Health (Dubai)
Our distributor in Dubai has presented EZSCAN from 24-27th January 2011.
IMPETO MEDICAL at EASD (European Association for the Study of Diabetes) congress, in Stockholm (Sweden)
We exhibited SUDOSCAN+ and EZSCAN from 20 to 24 September 2010.
Visasetia Sdn Bhd at Diabetes Asia 2010, Kuching, Serawak (Malaysia)
Our distributor in Malaysia presented EZSCAN at Diabetes Asia 2010 from 6-10 October 2010.
IMPETO MEDICAL at ADA (American Diabetes Association) congress, in Orlando, Florida (USA)
We exhibited SUDOSCAN and EZSCAN from 25 to 29 June 2010.
IMPETO MEDICAL at Deutsche Diabetes Gesellschaft (DDG), the German congress on diabetes, in Stuttgart (Germany)
We exhibited EZSCAN from 12 to 15 May 2010.
IMPETO MEDICAL at 6th World Congress on Prevention of Diabetes and its Complications (WCPD) in Dresden (Germany)
We has demonstrated eZscan from 8 to 11 April 2010 at the International Congress Center.
IMPETO MEDICAL au congrès SFD 2010 à LILLE (France)
Du 16 au 19 Mars, IMPETO MEDICAL a présenté EZSCAN pour la première fois au congrès SFD (Société Francophone du Diabète) à Lille, France. Grand Palais.
IMPETO MEDICAL at 1st International Adu Dhabi Diabetes Congress (ADDC) in Abu Dhabi (UAE)
We presented EZSCAN from 12 to 14 March 2010. Emirates Palace Hotel.
IMPETO MEDICAL at Diabetes UK Annual Professional Conference in Liverpool (United Kingdom)
From 3 to 5 March 2010, we exhibited eZscan with Aretaeus Ltd our UK distributor on stand E13. Arena and Convention Centre.
IMPETO MEDICAL at ARAB HEALTH/MED LAB 2010 in Dubai (UAE)
From January 25 to 28, IMPETO MEDICAL has demonstrated eZscan and has expanded its presence in Middle East at ARAB HEALTH/MED LAB 2010 in Dubai (U.A.E), Sheik Racheed Hall, booth RC19 (French Pavilion).
IMPETO MEDICAL at MEDICA 2009 in Dusseldorf (Germany)
From November 18 to 21, IMPETO MEDICAL has presented eZscan and its confirmed breakthrough results compared to Gold Standards.
IMPETO MEDICAL at Research Society for the Study of Diabetes in India (RSSDI) in Ahmedabad (India)
From November 5 to 8, Pr Ramachandran has presented the latest results of the longitudinal and FSOGTT study performed with eZscan in Chennaï.
IMPETO MEDICAL at IDF 2009 in Montreal (Canada)
IMPETO MEDICAL has presented 1 scientific communication, on October 18-22 in Montréal.
IMPETO MEDICAL at NEURODIAB 2009 in Toronto (Canada)
IMPETO MEDICAL has demonstrated eZscan and presented their latest results in diabetes complications, on October 15-17 in Toronto.
IMPETO MEDICAL at EASD 2009 in Vienna (Austria)
IMPETO MEDICAL has presented an accepted scientific communication. From September 29 to October 2, a large audience was welcome on booth H02 Hall B, to be tested by eZscan and become part of a european diabetes prevention program!
IMPETO MEDICAL at FEND 2009 in Vienna (Austria)
From September 24 to 26, a growing crowd attended our booth and experienced eZscan.
eZscan at MEDICAL FAIR THAILAND 2009 in Bangkok (Thailand)
IMPETO MEDICAL & FRANCO PACIFIC have showcased eZscan at Medical Fair Thailand, on September 16-18.
IMPETO MEDICAL at ADA 2009 in New Orleans (USA)
IMPETO MEDICAL has presented 3 posters in New Orleans, USA, on June 8-10.
IMPETO MEDICAL at CMEF 2009 in Shenzhen (China)
IMPETO MEDICAL was demonstrating eZscan at CMEF in Shenzhen, China, on April 18-21. booth H2D26.
IMPETO MEDICAL at PREDIABETES AND THE METABOLIC SYNDROME 2009 in Nice (France)
IMPETO MEDICAL was demonstrating eZscan at PREDIABETES AND THE METABOLIC SYNDROME in Nice, France, on april 1-4. booth 28.
IMPETO MEDICAL at DIABETES UK 2009 in Glasgow (UK)
IMPETO MEDICAL was demonstrating eZscan at DIABETES UK in Glasgow, March 11-13. booth D60.
IMPETO MEDICAL at ARAB HEALTH/MED LAB 2009 in Dubai (UAE)
IMPETO MEDICAL was demonstrating eZscan and has expanded its presence in Middle East at ARAB HEALTH/MED LAB 2009 in Dubai (U.A.E), January 26-29, 2009 (HALL Sheik Maktoum, booth MH28).
IMPETO MEDICAL at MEDICA 2008 in Dusseldorf (Germany)
IMPETO MEDICAL was demonstrating eZscan and has started expanding its network of distributors at MEDICA 2008, HALL 17, booth 17C24 in Dusseldorf, Germany, November 19-22, 2008.
IMPETO MEDICAL at the CSD 2008 in Xiamen (China)
IMPETO MEDICAL introduced eZscan at the Chinese Society for Diabetes in Xiamen, China, November 6-11, 2008.
IMPETO MEDICAL at the CHIF 2008 in Beijing (China)
IMPETO MEDICAL introduced eZscan at the Chinese Health Industry Forum in Beijing, China, October 30-November 2, 2008.
IMPETO MEDICAL CHINA opening in Beijing
To better support the expanding Chinese market with local sales force, IMPETO MEDICAL can now be locally reached at Unit 1501-1024, 15/F YinTai Office Tower, No.2 Jianguomenwai Ave, Beijing 100022, P.R. China [中国北京市，朝阳区建国门外大街2 号 北京银泰中心写字楼15 层1501-1023 室（邮编：100022)] Tel : +86-10-6563-7089 begin_of_the_skype_highlighting +86-10-6563-7089 end_of_the_skype_highlighting, Fax : +86-10-6563-7999
Quoris Capital leads Series A investment in IMPETO MEDICAL.
The U.S.-based Quoris Capital closed Series A funding with IMPETO MEDICAL on October 24. The company plans to use the proceeds to develop and market new products in the US as well as other regions including China and India.
IMPETO MEDICAL at the EASD 2008 in Roma (Italy)
IMPETO MEDICAL introduced eZscan at the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Rome, Italy, September 7-11, 2008.
Investments from HRE
IMPETO MEDICAL has completed a second round financing with the french holding HRE on june 1st, 2008. The contract secures funding of IMPETO MEDICAL’s ambitious R&D and marketing strategy.
EZSCAN approved in China
IMPETO MEDICAL announces SFDA registration approval of it’s EZSCAN device by the Chinese Authorities as of july 28th, 2008. The registration allows for immediate commercialisation of the device on the Chinese market.
Market introduction of EZSCAN
EZSCAN is first presented at the 5th World Congress on Prevention of Diabetes and its complications (WCPD) in Helsinki, June 1-4 2008.
IMPETO MEDICAL choses bb&b
IMPETO MEDICAL entrusts bb&b with the management of its global communication activities. bb&b specialises in Marketing and Communication for technology markets.